London-based Numan raises €51.6 million for the next era of preventative, digital healthcare

HealthTech startup Numan, a British digital health provider, announced today that it has raised €51.6 million in an extension of Numan’s Series B round to expand into female health and scale the platform’s infrastructure.

The funding is comprised of a new €25.8 million equity investment led by Big Pi Ventures through its new Growth Fund strategy. The round was joined by Endeavor Catalyst as well as existing investors: White Star Capital and Novator Partners. The fundraise also includes access to €23.2 million in growth capital from HSBC Innovation Banking.

Sokratis Papafloratos, CEO of Numan, commented: “Our latest funding is a testament to both our commercial performance and belief in our long-term vision for providing personalised, preventative health at scale. […] We are now perfectly positioned to expand our reach, deepen our clinical capabilities, and accelerate innovation to help our patients live happier, healthier, longer lives. 

“We started 2025 in a very strong position, one that allowed us to be genuinely choiceful about our next move. Over the past 18 months we’ve seen an explosion in demand – our patients have shown incredible engagement and achieved life-changing outcomes. This interest fuelled our growth and success in both reaching and maintaining profitability. That’s why we believe now is the time to invest in scaling what works and innovating for the future of healthcare.”

Founded in 2018, Numan offers personalised, integrated care in one digital platform – including clinical guidance, medication, behavioural health coaching, diagnostics and supplements, to help patients take control of their health. Their focus is on supporting people with stigmatised diseases and conditions – such as obesity and testosterone deficiency – which they believe are undertreated, mistreated or misunderstood.

The new capital comes on the heels of a landmark year for Numan, which saw revenue more than double year-on-year to €77.4 million by the end of 2024. Building on the profitability first achieved 18 months ago, Numan continues to scale rapidly and is on track to achieve 150% growth in 2025.

To date, the company has now treated over 650,000 patients across obesity management, men’s health, and diagnostics.

Nick Kalliagkopoulos, Partner at Big Pi Ventures, said:“Numan has demonstrated exceptional growth and a clear vision to tackle some of healthcare’s most pressing challenges, from obesity to hormonal health. We are excited to back a company that combines clinical rigour with technological innovation to deliver better health outcomes. The team’s focus on preventative care, patient engagement, and scalable technology sets Numan apart in the digital health sector.

“We’re confident that this infusion of capital will help Numan consolidate its leadership in the UK and pave the way for international expansion.”

The company explains that this latest investment will fuel their next phase of growth – accelerating momentum in the UK, expanding internationally, and unlocking access to new areas of care.

Specifically, the funding will power Numan’s expansion into female health and in deepening patient relationships through enhanced screening and preventative care programmes.

It will also go towards scaling the platform’s infrastructure to serve a growing patient base, expanding marketing efforts to reach more people in need, and advancing Numan’s AI-driven capabilities in a careful, clinically responsible manner.

Michael White, Head of Life Sciences at HSBC Innovation Banking UK, added: “HSBC Innovation Banking is proud to support Numan as it enters its next phase of growth. We partner with life sciences and healthcare companies at every stage of their growth to build banking and lending solutions that match their ambitions. Our team is committed to backing bold innovators, like Numan, equipping them with the tools they need to help them reach their next milestones. We look forward to seeing Numan continue to expand its reach across the UK and beyond.”

The post London-based Numan raises €51.6 million for the next era of preventative, digital healthcare appeared first on EU-Startups.